POMALIDOMIDE: A NOVEL PROMISING IMMUNOMODULATORY AGENT IN THE TREATMENT OF REFRACTORY AND RELAPSED MULTIPLE MYELOMA
Journal Title: Journal of Drug Discovery and Therapeutics - Year 2013, Vol 1, Issue 3
Abstract
Revival of thalidomide in the treatment of multiple myeloma (MM) has paved a path to search for compounds with increased antiangiogenic and anti-tumor effects, but decreased side-effects resulting in the development of thalidomide analogues .After lenalidomide, recently pomalidomide (3 amino thalidomide) has come up as a potential immunomodulatory drug (IMiD) which is found to be effective in relapsing and refractory MM. This novel agent has recently been approved by USFDA on 8th February, 2013. Pomalidomide differs from existing immunomodulatory agents in being extremely potent and safe in comparison. Lack of cross resistance with the existing agents offers advantage for its use in MM not responding to thalidomide, lenalidomide and bortezomib. Manageable myelosuppression is the only demonstrable effect observed. This review elucidates the available evidence on efficacy and safety of this drug in refractory and relapsing MM after analyzing various studies of this drug. Searches of pubmed, Cochrane database, Medscape, Google and clinicaltrial.org were made for terms like pomalidomide, multiple myeloma, immunomodulatory drugs.
Authors and Affiliations
Ruchika Nandha*| Assistant Professor, Department of Pharmacology, Dr Harvansh Singh Judge Institute of Dental Sciences, Panjab University, Chandigarh , India, Kavita Sekhri| Assistant Professor, Department of Pharmacology, Dr Harvansh Singh Judge Institute of Dental Sciences, Panjab University, Chandigarh , India, Harpal Singh| Consultant, Department of Critical Care, Max Superspeciality hospital, Phase 6, Mohali, India
Keywords
Related Articles
- EP ID EP1361
- DOI -
- Views 458
- Downloads 29
Androgenetic alopecia and its remedies - a review
Androgenetic alopecia commonly referred to as male and female pattern balding is the slow progressive loss of head hair in a discrete pattern, sometimes to the level of baldness. Androgenetic alopecia and alopecia areata...
Formulation and evaluation of aspirin, paracitamol and serratiopeptidase tablet conventional dosage form an overview
The present studies are based on the single nsaid drug dosage form or on the combination of nsaid along with analgesic. Some drug combination also provides pain relief with proteolytic enzyme that prevents the GI bleedin...
STUDY TO EVALUATE PRESCRIPTION PATTERNS AND KNOWLEDGE ABOUT COMMON ALLOPATHIC DRUGS AMONG UNQUALIFIED RURAL MEDICAL PRACTITIONERS
AIMS AND OBJECTIVES: To evaluate the prescription patterns and knowledge about common allopathic drugs among the unqualified rural medical practitioners in Pinjore block of Panchkula district, Haryana MATERIAL AND METHOD...
NATURAL SOURCE WITH POWER FOR TREATMENT OF CANCER: A RECENT REVIEW
Cancer is a major public health burden in both developed and developing countries. Studies have estimated that genetic factors cause only 5–10% of all human cancers, while the remaining percentage is caused by lifestyle....
CNS AGENTS ON HIV/AIDS: OVERVIEW
HIV/AIDS patients suffering from depression more often treated with various drugs like Methylphenidate, Dextroamphetamine to treat depression and also with psychoactive drugs to treat side effects like insomnia. Sometime...